Effect of topical application of mitomycin-C on wound healing in a postlaminectomy rat model: An experimental study

被引:25
作者
Su, Changhui [1 ]
Sui, Tao [1 ]
Zhang, Xishan [2 ]
Zhang, Hui [2 ]
Cao, Xiaojian [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Orthoped, Nanjing 210029, Jiangsu, Peoples R China
[2] Taishan Med Coll, Affiliated Hosp, Dept Orthoped, Taishan, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Mitomycin-C; Wound healing; Capillary; Vascular endothelial growth factor; Laminectomy; ENDOTHELIAL GROWTH-FACTOR; HUMAN SURGICAL WOUNDS; EPIDURAL FIBROSIS; LAMINECTOMY MODEL; PHOTOREFRACTIVE KERATECTOMY; SCAR FORMATION; 5-FLUOROURACIL; ANGIOGENESIS; ADHESION; SURGERY;
D O I
10.1016/j.ejphar.2011.10.028
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to investigate the effects of topical application mitomycin-C (MMC) on wound healing after laminectomy. 60 adult male SD rats were equally and randomly divided into five groups. Laminectomy was performed at the level of L1 in all rats. After hemostasis was achieved, cotton pads soaked with saline and MMC (0.1 mg/ml, 0.3 mg/ml, 0.5 mg/ml and 0.7 mg/ml) were directly subjected to the exposed dura for 5 min in each group. Two weeks after laminectomy all the rats were killed. The vertebral column including the back scar tissue and muscles was obtained to make paraffin sections. The hematoxylin-eosin staining and Masson staining were performed with the obtained paraffin sections. The number of the fibroblast and the capillary density were counted by the hematoxylin-eosin staining slice. The extent of epidural fibrosis and the expression of vascular endothelial growth factor (VEGF) were evaluated by the immunohistochemical slice through a computer image analysis system. Our data showed that the number of fibroblast, capillary density and fibrotic tissue in the 0.5 and 0.7 mg/ml MMC groups was significantly lower than the control, 0.1 and 0.3 mg/ml MMC groups; while the expression of VEGF in control and 0.1 mg/ml MMC groups was notably higher than 0.3, 0.5 and 0.7 mg/ml MMC groups. Topical application of MMC above the concentration of 0.3 mg/ml could affect all steps of the wound healing process via inhibiting the angiogenesis and fibroblast proliferation, thus delayed the wound healing after laminectomy. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 28 条
[1]  
ANDO H, 1992, OPHTHALMOLOGY, V99, P1809
[2]  
Browder T, 2000, CANCER RES, V60, P1878
[3]   Angiogenesis induction and regression in human surgical wounds [J].
Brown, NJ ;
Smyth, EAE ;
Cross, SS ;
Reed, MWR .
WOUND REPAIR AND REGENERATION, 2002, 10 (04) :245-251
[4]   Mitomycin C for the prevention of adhesion formation after endoscopic sinus surgery: A randomized, controlled study [J].
Chung, JH ;
Cosenza, MJ ;
Rahbar, R ;
Metson, RB .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2002, 126 (05) :468-474
[5]   The effects of mitomycin C and 5-fluorouracil/triamcinolone on fibrosis/scar tissue formation secondary to subglottic trauma (experimental study) [J].
Cincik, H ;
Gungor, A ;
Cakmak, A ;
Omeroglu, A ;
Poyrazoglu, E ;
Yidirim, S ;
Cekin, E ;
Candan, H .
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2005, 26 (01) :45-50
[6]   Effects of amniotic membrane transplantation and mitomycin C on wound healing in experimental glaucoma surgery [J].
Demir, T ;
Turgut, B ;
Akyol, N ;
Ozercan, I ;
Ulas, F ;
Celiker, U .
OPHTHALMOLOGICA, 2002, 216 (06) :438-442
[7]   Topical mitomycin C-induced inhibition of postlaminectomy peridural fibrosis in rabbits [J].
Dogulu, F ;
Kurt, G ;
Emmez, H ;
Erdem, O ;
Memis, L ;
Baykaner, K ;
Ceviker, N .
JOURNAL OF NEUROSURGERY, 2003, 99 (01) :76-79
[8]   Time and dose effects of mitomycin C on extracellular matrix fibroblasts and proteins [J].
Ferguson, B ;
Gray, SD ;
Thibeault, S .
LARYNGOSCOPE, 2005, 115 (01) :110-115
[9]   Role of vascular endothelial growth factor in Physiologic and Pathologic angiogenesis: Therapeutic implications [J].
Ferrara, N .
SEMINARS IN ONCOLOGY, 2002, 29 (06) :10-14
[10]   Vascular endothelial growth factor [J].
Ferrara, N .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (14) :2413-2422